Identification of peripheral CD154+ T cells and HLA-DRB1 as biomarkers of acute cellular rejection in adult liver transplant recipients. (29th October 2020)
- Record Type:
- Journal Article
- Title:
- Identification of peripheral CD154+ T cells and HLA-DRB1 as biomarkers of acute cellular rejection in adult liver transplant recipients. (29th October 2020)
- Main Title:
- Identification of peripheral CD154+ T cells and HLA-DRB1 as biomarkers of acute cellular rejection in adult liver transplant recipients
- Authors:
- Boix, F
Legaz, I
Minhas, A
Alfaro, R
Jiménez–Coll, V
Mrowiec, A
Martínez–Banaclocha, H
Galián, J A
Botella, C
Moya–Quiles, M R
Sanchez–Bueno, F
Robles, R
de la Peña–Moral, J
Ramirez, P
Pons, J A
Minguela, A
Muro, M - Abstract:
- Summary: Decreasing graft rejection and increasing graft and patient survival are great challenges facing liver transplantation (LT). Different T cell subsets participate in the acute cellular rejection (ACR) of the allograft. Cell-mediated immunity markers of the recipient could help to understand the mechanisms underlying acute rejection. This study aimed to analyse different surface antigens on T cells in a cohort of adult liver patients undergoing LT to determine the influence on ACR using multi-parametric flow cytometry functional assay. Thirty patients were monitored at baseline and during 1 year post-transplant. Two groups were established, with (ACR) and without (NACR) acute cellular rejection. Leukocyte, total lymphocyte, percentages of CD4 + CD154 + and CD8 + CD154 + T cells, human leukocyte antigen (HLA) mismatch between recipient–donor and their relation with ACR as well as the acute rejection frequencies were analysed. T cells were stimulated with concanavalin A (Con-A) and surface antigens were analysed by fluorescence activated cell sorter (FACS) analysis. A high percentage of CD4 + CD154 + T cells ( P = 0·001) and a low percentage of CD8 + CD154 + T cells ( P = 0·002) at baseline were statistically significant in ACR. A receiver operating characteristic analysis determined the cut-off values capable to stratify patients at high risk of ACR with high sensitivity and specificity for CD4 + CD154 + ( P = 0·001) and CD8 + CD154 + T cells ( P = 0·002). In logisticSummary: Decreasing graft rejection and increasing graft and patient survival are great challenges facing liver transplantation (LT). Different T cell subsets participate in the acute cellular rejection (ACR) of the allograft. Cell-mediated immunity markers of the recipient could help to understand the mechanisms underlying acute rejection. This study aimed to analyse different surface antigens on T cells in a cohort of adult liver patients undergoing LT to determine the influence on ACR using multi-parametric flow cytometry functional assay. Thirty patients were monitored at baseline and during 1 year post-transplant. Two groups were established, with (ACR) and without (NACR) acute cellular rejection. Leukocyte, total lymphocyte, percentages of CD4 + CD154 + and CD8 + CD154 + T cells, human leukocyte antigen (HLA) mismatch between recipient–donor and their relation with ACR as well as the acute rejection frequencies were analysed. T cells were stimulated with concanavalin A (Con-A) and surface antigens were analysed by fluorescence activated cell sorter (FACS) analysis. A high percentage of CD4 + CD154 + T cells ( P = 0·001) and a low percentage of CD8 + CD154 + T cells ( P = 0·002) at baseline were statistically significant in ACR. A receiver operating characteristic analysis determined the cut-off values capable to stratify patients at high risk of ACR with high sensitivity and specificity for CD4 + CD154 + ( P = 0·001) and CD8 + CD154 + T cells ( P = 0·002). In logistic regression analysis, CD4 + CD154 +, CD8 + CD154 + and HLA mismatch were confirmed as independent risk factors to ACR. Post-transplant percentages of both T cell subsets were significantly higher in ACR, despite variations compared to pretransplant. These findings support the selection of candidates for LT based on the pretransplant percentages of CD4 + CD154 + and CD8 + CD154 + T cells in parallel with other transplant factors. Graphical Abstract: … (more)
- Is Part Of:
- Clinical and experimental immunology. Volume 203:Number 2(2021)
- Journal:
- Clinical and experimental immunology
- Issue:
- Volume 203:Number 2(2021)
- Issue Display:
- Volume 203, Issue 2 (2021)
- Year:
- 2021
- Volume:
- 203
- Issue:
- 2
- Issue Sort Value:
- 2021-0203-0002-0000
- Page Start:
- 315
- Page End:
- 328
- Publication Date:
- 2020-10-29
- Subjects:
- acute cellular rejection -- CD154+ T cells -- cell-mediated immunity (CMI) -- HLA -- immunosuppression -- liver transplantation
Immunopathology -- Periodicals
616.079 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1365-2249 ↗
https://academic.oup.com/cei ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/cei.13533 ↗
- Languages:
- English
- ISSNs:
- 0009-9104
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3286.251000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 26510.xml